. iStock
Cash Flow - Recent 8 Quarters (Free Cash Flow = Operating Cash Flow - Investing Cash Flow)
Numbers in millionsOperating Cash FlowInvesting Cash FlowFree Cash FlowNet Income
2024-06-17814600281940
2024-031090173228223115
2023-125240-10995-5755-3368
2023-1034568874343-2382
2023-07-1208-25484-266922327
2023-041212331545275543
2022-128581-441041714993
2022-105968-62653418608
Cash Flow - Recent 5 Years (Free Cash Flow = Operating Cash Flow - Investing Cash Flow)
Numbers in millionsOperating Cash FlowInvesting Cash FlowFree Cash FlowNet Income
2023-128700-32278-235772119
2022-1229267-157831348331372
2021-1232922-225341038721979
2020-1210586-418863989616

People Also Ask

pfizer capital structure analysis financial analysis and performance evaluation pfizer financial statements 2022 abbvie financial analysis financial analysis of johnson and johnson astrazeneca ratio analysis merck and co financial ratios gsk financial ratios

Financial Analysis Related Information

Pfizer Financial Ratios for Analysis 2009-2022 | PFE - Macrotrends
Pfizer Inc. (NYSE:PFE) | Financial Analysis and Stock Valuation
PFE | Pfizer Inc. Financial Statements - WSJ
Pfizer (PFE) Financial Summary - Investing.com India
Pfizer (PFE) Financial Ratios - Investing.com
Pfizer Key Financial Ratios, Pfizer Financial Statement & Accounts
PFE - Pfizer Inc Financials & Balance Sheets - NYSE - Morningstar
Pfizer, Inc. Common Stock (PFE) Financials - Nasdaq
Financial Data Analytics - AI-Powered Financial Analytics
Re-investing in Innovation - Cash Dividends for Investors

Disclaimer

All the information on the website is for reference only. If the user trades according to this information, he/she shall be responsible for any transaction loss. This website is not responsible for any errors in the content of the information or delay in updating.